Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 64

Similar articles for PubMed (Select 23467735)

1.

Plasma Vitamin D Levels And Vitamin D Receptor Polymorphisms Are Associated with Survival of Non-small Cell Lung Cancer.

Liu Y, Chen W, Hu ZB, Xu L, Shu YQ, Pan SY, Dai JC, Jin GF, Ma HX, Shen HB.

Chin J Cancer Res. 2011 Mar;23(1):33-7. doi: 10.1007/s11670-011-0033-3.

2.

Vitamin D receptor polymorphisms in differentiated thyroid carcinoma.

Penna-Martinez M, Ramos-Lopez E, Stern J, Hinsch N, Hansmann ML, Selkinski I, Grünwald F, Vorländer C, Wahl RA, Bechstein WO, Zeuzem S, Holzer K, Badenhoop K.

Thyroid. 2009 Jun;19(6):623-8. doi: 10.1089/thy.2008.0388.

PMID:
19499989
3.

Prognostic assessment of apoptotic gene polymorphisms in non-small cell lung cancer in Chinese.

Cao S, Wang C, Huang X, Dai J, Hu L, Liu Y, Chen J, Ma H, Jin G, Hu Z, Xu L, Shen H.

J Biomed Res. 2013 May;27(3):231-8. doi: 10.7555/JBR.27.20130014. Epub 2013 Apr 25.

4.

Combined effect of 25-OH vitamin D plasma levels and genetic vitamin D receptor (NR 1I1) variants on fibrosis progression rate in HCV patients.

Baur K, Mertens JC, Schmitt J, Iwata R, Stieger B, Eloranta JJ, Frei P, Stickel F, Dill MT, Seifert B, Ferrari HA, von Eckardstein A, Bochud PY, Müllhaupt B, Geier A; Swiss Hepatitis C Cohort Study Group.

Liver Int. 2012 Apr;32(4):635-43. doi: 10.1111/j.1478-3231.2011.02674.x. Epub 2011 Dec 8.

PMID:
22151003
5.

Polymorphisms of key chemokine genes and survival of non-small cell lung cancer in Chinese.

Ma H, Shu Y, Pan S, Chen J, Dai J, Jin G, Hu Z, Shen H.

Lung Cancer. 2011 Nov;74(2):164-9. doi: 10.1016/j.lungcan.2011.03.005. Epub 2011 Apr 22.

PMID:
21514686
6.

Polymorphisms in EGFR and VEGF contribute to non-small-cell lung cancer survival in a Chinese population.

Dong J, Dai J, Shu Y, Pan S, Xu L, Chen W, Wang Y, Jin G, Ma H, Zhang M, Hu Z, Shen H.

Carcinogenesis. 2010 Jun;31(6):1080-6. doi: 10.1093/carcin/bgq079. Epub 2010 Apr 16.

7.

Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer.

Heist RS, Zhou W, Wang Z, Liu G, Neuberg D, Su L, Asomaning K, Hollis BW, Lynch TJ, Wain JC, Giovannucci E, Christiani DC.

J Clin Oncol. 2008 Dec 1;26(34):5596-602. doi: 10.1200/JCO.2008.18.0406. Epub 2008 Oct 20.

8.

Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?

Porojnicu AC, Robsahm TE, Dahlback A, Berg JP, Christiani D, Bruland OS, Moan J.

Lung Cancer. 2007 Mar;55(3):263-70. Epub 2007 Jan 17.

PMID:
17207891
9.

The association of vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D levels with generalized vitiligo.

Li K, Shi Q, Yang L, Li X, Liu L, Wang L, Li Q, Wang G, Li CY, Gao TW.

Br J Dermatol. 2012 Oct;167(4):815-21. doi: 10.1111/j.1365-2133.2012.11132.x.

PMID:
22762534
10.

Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population.

Obara W, Suzuki Y, Kato K, Tanji S, Konda R, Fujioka T.

Int J Urol. 2007 Jun;14(6):483-7.

PMID:
17593089
11.

Why vitamin D for cancer patients?

Gandini S, Francesco F, Johanson H, Bonanni B, Testori A.

Ecancermedicalscience. 2009;3:160. doi: 10.3332/ecancer.2009.160. Epub 2009 Sep 30.

12.

Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk.

Reimers LL, Crew KD, Bradshaw PT, Santella RM, Steck SE, Sirosh I, Terry MB, Hershman DL, Shane E, Cremers S, Dworakowski E, Teitelbaum SL, Neugut AI, Gammon MD.

Cancer Causes Control. 2015 Feb;26(2):187-203. doi: 10.1007/s10552-014-0497-9. Epub 2014 Nov 25.

PMID:
25421379
13.

Potentially functional polymorphisms in cell cycle genes and the survival of non-small cell lung cancer in a Chinese population.

Ma H, Chen J, Pan S, Dai J, Jin G, Hu Z, Shen H, Shu Y.

Lung Cancer. 2011 Jul;73(1):32-7. doi: 10.1016/j.lungcan.2010.11.001. Epub 2010 Dec 9.

PMID:
21145615
14.

Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients.

Zhou W, Heist RS, Liu G, Asomaning K, Neuberg DS, Hollis BW, Wain JC, Lynch TJ, Giovannucci E, Su L, Christiani DC.

J Clin Oncol. 2007 Feb 10;25(5):479-85.

15.

Polymorphisms of vitamin D receptor and survival in early-stage non-small cell lung cancer patients.

Zhou W, Heist RS, Liu G, Neuberg DS, Asomaning K, Su L, Wain JC, Lynch TJ, Giovannucci E, Christiani DC.

Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2239-45.

16.

MDM2 SNP309 contributes to non-small cell lung cancer survival in Chinese.

Dong J, Ren B, Hu Z, Chen J, Hu L, Dai J, Jin G, Xu L, Shen H.

Mol Carcinog. 2011 Jun;50(6):433-8. doi: 10.1002/mc.20727. Epub 2011 Jan 25.

PMID:
21268124
17.

Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.

Lee Y, Yoon KA, Joo J, Lee D, Bae K, Han JY, Lee JS.

Carcinogenesis. 2013 Feb;34(2):307-13. doi: 10.1093/carcin/bgs356. Epub 2012 Nov 8.

18.

Association study on two vitamin D receptor gene polymorphisms and vitamin D metabolites in multiple sclerosis.

Smolders J, Damoiseaux J, Menheere P, Tervaert JW, Hupperts R.

Ann N Y Acad Sci. 2009 Sep;1173:515-20. doi: 10.1111/j.1749-6632.2009.04656.x.

PMID:
19758194
19.

The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature.

Köstner K, Denzer N, Müller CS, Klein R, Tilgen W, Reichrath J.

Anticancer Res. 2009 Sep;29(9):3511-36. Review.

20.

Genetic variants of NBS1 predict clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer in Chinese.

Xu JL, Hu LM, Huang MD, Zhao W, Yin YM, Hu ZB, Ma HX, Shen HB, Shu YQ.

Asian Pac J Cancer Prev. 2012;13(3):851-6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk